Recent Finacing
Recent Raise
Gotham Therapeutics develops small-molecule drugs targeting RNA-modifying proteins using an epitranscriptomics platform that evaluates protein impact on disease biology to generate oncology, autoimmune, and neurodegeneration programs.
